While Marketing driven phase IV programmes are coming increasingly under the regulatory spot-light. Identification of commercially valuable clinical research opportunities.
Small changes can often, at minimal extra cost, greatly increase the commercial value of the study.
Qualitative Research to highlight commercially significant opportunities. Management of advisory boards to produce maximum value for your investment. Design of clinical protocols that generate data of immediate relevance to the non-academic clinician. Development of commercial communications messages linked to clinical programmes. Development of enthusiastic clinical advocates through relationship development.